FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]FDAFDA PCAC reviews BPC-157, KPV, TB-500, MOTS-c (Jul 23) and DSIP, Semax, Epitalon (Jul 24, 2026) for 503A compounding eligibilityUPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORY12 peptides removed from FDA Category 2 (Apr 23, 2026) — removal is not approval; all remain pending PCAC reviewREGULATORYNo formal FDA reclassification published — no restricted peptide is legal to compound; 5 more peptides go to PCAC before Feb 2027RESEARCHA Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy [NCT07881783]RESEARCHStudy to Evaluate the Dose-Dependent Effect of Tirzepatide on Gastric Emptying in Adult Patients With Type 1 Diabetes [NCT07951658]RESEARCHA Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity [NCT06037252]RESEARCHA Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine [NCT07729462]RESEARCHHypersensitivity to Amylin in Post-Traumatic Headache [NCT07340775]RESEARCHEffects of Tirzepatide on Corneal Nerve Morphology and Other Ocular Parameters in Adults With Obesity [NCT07950371]NEWSSTAT+: Peptide market poised to explode with new Hims and Noom launchesRESEARCHAlleviating Carbohydrate Counting for Patients With Type-1 Diabetes Using a Closed Loop System With Weekly Subcutaneous Semaglutide [NCT06387199]RESEARCHWeight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity [NCT07423481]RESEARCHSEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years [NCT07845994]

Solo a fini di ricerca. Disposizione completa →

Contatti

Ogni persona e organizzazione che sta modellando il paesaggio dei peptidi — ricercatori che pubblicano la scienza, clinici che lo applicano, influencer che l'amplificano e aziende farmaceutiche che lo portano al mercato.

20 risultati

EL
Eli Lilly
Pharma
Indianapolis, USA

Eli Lilly was an American businessman who founded Eli Lilly and Company, a pharmaceutical company known for developing medications including tirzepatide and dulaglutide.

Novo Nordisk
Novo Nordisk
Pharma
Bagsvaerd, Denmark

Novo Nordisk is a Danish pharmaceutical company focused on diabetes and obesity treatments, known for products like semaglutide and liraglutide.

A
AbbVie
Pharma
North Chicago, USA

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois, known for producing drugs to treat a variety of medical conditions and conducting extensive clinical research.

Amgen
Amgen
Pharma
Thousand Oaks, USA

Amgen Inc. is a leading American biopharmaceutical company headquartered in Thousand Oaks, California, specializing in the development and commercialization of innovative therapies for severe diseases such as osteoporosis, hyperlipidemia, and autoimmune disorders.

AstraZeneca
AstraZeneca
Pharma
Cambridge, UK

AstraZeneca is a multinational pharmaceutical and biotechnology company headquartered in Cambridge, UK. It focuses on developing treatments for major diseases such as oncology, cardiovascular conditions, and diabetes.

B
Bachem
Pharma
Bubendorf, Switzerland

Bachem is a Swiss company known for peptide manufacturing and the production of GLP-1 APIs.

BT
Bicycle Therapeutics
Pharma
Cambridge, UK

UK-based biopharma developing Bicycle drug conjugates (BDCs) — fully synthetic constrained bicyclic peptides for cancer. Lead candidate zeladenoson targets Nectin-4 in solid tumors. NASDAQ: BCYC.

Ferring Pharmaceuticals
Ferring Pharmaceuticals
Pharma
Saint-Prex, Switzerland

Ferring Pharmaceuticals is a Swiss multinational biopharmaceutical company specializing in reproductive health, maternal health, gastroenterology, and urology. It has been developing treatments for mothers and babies for over five decades.

G
Genentech
Pharma
San Francisco, USA

Genentech is an American biotechnology company based in South San Francisco, California, operating as a subsidiary of Roche. It focuses on developing and manufacturing innovative pharmaceutical products.

I
Ipsen
Pharma
Paris, France

Ipsen is a French biopharmaceutical company founded in 1929, focusing on drug development and commercialization in oncology, rare diseases, and neuroscience. The company operates globally with presence in over 30 countries.

Lonza Group
Lonza Group
Pharma
Basel, Switzerland

Lonza Group AG is a Swiss multinational company providing custom manufacturing services for biopharmaceuticals and offering product development support in the pharmaceutical, biotechnology, and nutrition sectors.

Merck
Merck
Pharma
Rahway, USA

Merck & Co., Inc. is a leading pharmaceutical company known for its cancer treatments and vaccines, notably Keytruda (pembrolizumab) and Gardasil.

Pfizer
Pfizer
Pharma
New York, USA

Pfizer Inc. is a leading pharmaceutical company founded in 1849, specializing in the development and production of medications and vaccines for various medical conditions.

PG
Polypeptide Group
Pharma
Strasbourg, France

Polypeptide Group is a pharmaceutical company focusing on peptide contract manufacturing and research, notably involving semaglutide API and various clinical studies related to peptides and incretin hormones.

PT
Protagonist Therapeutics
Pharma
Newark, USA

Protagonist Therapeutics is a pharmaceutical company developing rusfertide for polycythemia vera, with regulatory designations and an FDA New Drug Application submission.

RP
Ra Pharmaceuticals
Pharma
Cambridge, USA

Clinical-stage biopharma focused on complement system disorders. Developed zilucoplan (Zilbrysq), a macrocyclic peptide C5 inhibitor for myasthenia gravis. Acquired by UCB in 2020.

RH
Radius Health
Pharma
Boston, USA

Radius Health is a pharmaceutical company known for developing and selling abaloparatide, a medication used to treat osteoporosis. The company also conducts research on bone health and metabolism.

SP
Sun Pharmaceutical
Pharma
Mumbai, India

Sun Pharmaceutical Industries Limited is a leading Indian multinational pharmaceutical company with global operations, specializing in the manufacture and sale of pharmaceutical formulations and APIs across over 100 countries.

Teva Pharmaceutical
Teva Pharmaceutical
Pharma
Tel Aviv, Israel

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company specializing in generic drugs and branded medications such as Austedo for Huntington's chorea and tardive dyskinesia, and Ajovy (fremanezumab) for migraine prevention.

Zealand Pharma
Zealand Pharma
Pharma
Copenhagen, Denmark

Zealand Pharma A/S is a Danish biotechnology company based in Søborg, Copenhagen, focusing on the development of peptide-based medicines for metabolic diseases such as diabetes and obesity. The company has a subsidiary in the US and participates in clinical trials for various cancers and autoimmune conditions.